Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID P08235 4306 NR3C2 MCR MLR Colorectal cancer Phosphorylation N T3 P08235 4306 NR3C2 MCR MLR Colorectal cancer Phosphorylation N Y6 P08235 4306 NR3C2 MCR MLR Colorectal cancer Phosphorylation N S8 P08235 4306 NR3C2 MCR MLR Autosomal dominant pseudohypoaldosteronism Phosphorylation N S111 P08235 4306 NR3C2 MCR MLR Uterine corpus endometrial carcinoma Phosphorylation N S111 P08235 4306 NR3C2 MCR MLR Autosomal dominant pseudohypoaldosteronism Phosphorylation N S129 P08235 4306 NR3C2 MCR MLR Lung adenocarcinoma Phosphorylation N S168 P08235 4306 NR3C2 MCR MLR Skin cutaneous melanoma Phosphorylation N S168 P08235 4306 NR3C2 MCR MLR Stomach adenocarcinoma Phosphorylation N S168 P08235 4306 NR3C2 MCR MLR Autosomal dominant pseudohypoaldosteronism Phosphorylation N S183 P08235 4306 NR3C2 MCR MLR Colon adenocarcinoma Phosphorylation N S183 P08235 4306 NR3C2 MCR MLR Hepatocellular carcinoma Phosphorylation N S183 P08235 4306 NR3C2 MCR MLR Skin cutaneous melanoma Phosphorylation N S183 P08235 4306 NR3C2 MCR MLR Colon adenocarcinoma Phosphorylation C S196 P08235 4306 NR3C2 MCR MLR Bladder urothelial carcinoma Phosphorylation N S196 P08235 4306 NR3C2 MCR MLR Hepatocellular carcinoma Phosphorylation N S227 P08235 4306 NR3C2 MCR MLR Lung squamous cell carcinoma Phosphorylation N S238 P08235 4306 NR3C2 MCR MLR Autosomal dominant pseudohypoaldosteronism Phosphorylation N S250 P08235 4306 NR3C2 MCR MLR Bladder urothelial carcinoma Phosphorylation N S250 P08235 4306 NR3C2 MCR MLR Glioblastoma multiforme Phosphorylation N S250 P08235 4306 NR3C2 MCR MLR Transitional cell carcinoma Phosphorylation N S250 P08235 4306 NR3C2 MCR MLR Autosomal dominant pseudohypoaldosteronism Phosphorylation N S255 P08235 4306 NR3C2 MCR MLR Autosomal dominant pseudohypoaldosteronism Phosphorylation C S259 P08235 4306 NR3C2 MCR MLR Skin cutaneous melanoma Phosphorylation N S259 P08235 4306 NR3C2 MCR MLR Autosomal dominant pseudohypoaldosteronism Phosphorylation N S262 P08235 4306 NR3C2 MCR MLR Skin cutaneous melanoma Phosphorylation N S262 P08235 4306 NR3C2 MCR MLR Autosomal dominant pseudohypoaldosteronism Phosphorylation N S263 P08235 4306 NR3C2 MCR MLR Skin cutaneous melanoma Phosphorylation N S263 P08235 4306 NR3C2 MCR MLR Autosomal dominant pseudohypoaldosteronism Phosphorylation N S274 P08235 4306 NR3C2 MCR MLR Breast invasive carcinoma Phosphorylation N S274 P08235 4306 NR3C2 MCR MLR Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S274 P08235 4306 NR3C2 MCR MLR Skin cutaneous melanoma Phosphorylation N S274 P08235 4306 NR3C2 MCR MLR Breast invasive carcinoma Phosphorylation N S283 P08235 4306 NR3C2 MCR MLR Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S283 P08235 4306 NR3C2 MCR MLR Autosomal dominant pseudohypoaldosteronism Phosphorylation N S311 P08235 4306 NR3C2 MCR MLR Stomach adenocarcinoma Phosphorylation N S311 P08235 4306 NR3C2 MCR MLR Autosomal dominant pseudohypoaldosteronism Phosphorylation N S361 P08235 4306 NR3C2 MCR MLR Breast invasive carcinoma Phosphorylation N S361 P08235 4306 NR3C2 MCR MLR Lung adenocarcinoma Phosphorylation N S361 P08235 4306 NR3C2 MCR MLR Non-Hodgkin's lymphoma Phosphorylation N S361 P08235 4306 NR3C2 MCR MLR Head and neck squamous cell carcinoma Phosphorylation N S424 P08235 4306 NR3C2 MCR MLR Head and neck squamous cell carcinoma SUMOylation N K428 P08235 4306 NR3C2 MCR MLR Autosomal dominant pseudohypoaldosteronism Phosphorylation N S459 P08235 4306 NR3C2 MCR MLR Head and neck squamous cell carcinoma Phosphorylation N S459 P08235 4306 NR3C2 MCR MLR Skin cutaneous melanoma SUMOylation N K494 P08235 4306 NR3C2 MCR MLR Stomach adenocarcinoma Phosphorylation N S543 P08235 4306 NR3C2 MCR MLR Autosomal dominant pseudohypoaldosteronism Phosphorylation N S703 P08235 4306 NR3C2 MCR MLR Lung squamous cell carcinoma Phosphorylation N T735 P08235 4306 NR3C2 MCR MLR Skin cutaneous melanoma Phosphorylation N T735 P08235 4306 NR3C2 MCR MLR Lung squamous cell carcinoma Phosphorylation N S737 P08235 4306 NR3C2 MCR MLR Skin cutaneous melanoma Phosphorylation N S737 P08235 4306 NR3C2 MCR MLR Pseudohypoaldosteronism Phosphorylation N T761 P08235 4306 NR3C2 MCR MLR Pseudohypoaldosteronism Phosphorylation N T800 P08235 4306 NR3C2 MCR MLR Breast invasive carcinoma SUMOylation N K953 P08235 4306 NR3C2 MCR MLR Skin cutaneous melanoma SUMOylation N K953 P08235 4306 NR3C2 MCR MLR Stomach adenocarcinoma SUMOylation N K953 P08235 4306 NR3C2 MCR MLR Pseudohypoaldosteronism Ubiquitination N K970 P08235 4306 NR3C2 MCR MLR Pseudohypoaldosteronism Ubiquitination N K977 Q13618 8452 CUL3 KIAA0617 Kidney cancer Acetylation N S2 Q13618 8452 CUL3 KIAA0617 Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K47 Q13618 8452 CUL3 KIAA0617 Lung adenocarcinoma Ubiquitination N K47 Q13618 8452 CUL3 KIAA0617 Kidney renal papillary cell carcinoma Phosphorylation N Y58 Q13618 8452 CUL3 KIAA0617 Lung adenocarcinoma Phosphorylation N Y58 Q13618 8452 CUL3 KIAA0617 Renal cell carcinoma Phosphorylation N Y58 Q13618 8452 CUL3 KIAA0617 Bladder urothelial carcinoma Phosphorylation N T63 Q13618 8452 CUL3 KIAA0617 Kidney renal papillary cell carcinoma Phosphorylation N T63 Q13618 8452 CUL3 KIAA0617 Lung adenocarcinoma Phosphorylation N T63 Q13618 8452 CUL3 KIAA0617 Renal cell carcinoma Phosphorylation N T63 Q13618 8452 CUL3 KIAA0617 Bladder urothelial carcinoma Ubiquitination N K68 Q13618 8452 CUL3 KIAA0617 Lung adenocarcinoma Ubiquitination N K68 Q13618 8452 CUL3 KIAA0617 Bladder urothelial carcinoma Ubiquitination N K72 Q13618 8452 CUL3 KIAA0617 Kidney renal papillary cell carcinoma Ubiquitination N K72 Q13618 8452 CUL3 KIAA0617 Lung adenocarcinoma Ubiquitination N K72 Q13618 8452 CUL3 KIAA0617 Bladder urothelial carcinoma Ubiquitination N K254 Q13618 8452 CUL3 KIAA0617 Ovarian adenocarcinoma Ubiquitination N K254 Q13618 8452 CUL3 KIAA0617 Bladder urothelial carcinoma Ubiquitination N K262 Q13618 8452 CUL3 KIAA0617 Ovarian adenocarcinoma Ubiquitination N K262 Q13618 8452 CUL3 KIAA0617 Stomach adenocarcinoma Ubiquitination N K262 Q13618 8452 CUL3 KIAA0617 Head and neck squamous cell carcinoma Ubiquitination N K292 Q13618 8452 CUL3 KIAA0617 Prostate adenocarcinoma Ubiquitination N K292 Q13618 8452 CUL3 KIAA0617 Prostate adenocarcinoma Ubiquitination N K301 Q13618 8452 CUL3 KIAA0617 Bladder urothelial carcinoma Ubiquitination N K326 Q13618 8452 CUL3 KIAA0617 Head and neck squamous cell carcinoma Ubiquitination N K326 Q13618 8452 CUL3 KIAA0617 Lung squamous cell carcinoma Ubiquitination N K326 Q13618 8452 CUL3 KIAA0617 Uterine corpus endometrial carcinoma Ubiquitination N K326 Q13618 8452 CUL3 KIAA0617 Bladder urothelial carcinoma Ubiquitination N K336 Q13618 8452 CUL3 KIAA0617 Skin cutaneous melanoma Ubiquitination N K349 Q13618 8452 CUL3 KIAA0617 Kidney renal papillary cell carcinoma Methylation N R364 Q13618 8452 CUL3 KIAA0617 Testicular germ cell tumor Phosphorylation N Y387 Q13618 8452 CUL3 KIAA0617 Prostate adenocarcinoma Ubiquitination N K395 Q13618 8452 CUL3 KIAA0617 Prostate adenocarcinoma Ubiquitination N K401 Q13618 8452 CUL3 KIAA0617 Pseudohypoaldosteronism Ubiquitination N K414 Q13618 8452 CUL3 KIAA0617 Bladder urothelial carcinoma Ubiquitination N K425 Q13618 8452 CUL3 KIAA0617 Head and neck squamous cell carcinoma Ubiquitination N K425 Q13618 8452 CUL3 KIAA0617 Bladder urothelial carcinoma Ubiquitination N K433 Q13618 8452 CUL3 KIAA0617 Head and neck squamous cell carcinoma Ubiquitination N K433 Q13618 8452 CUL3 KIAA0617 Kidney renal clear cell carcinoma Phosphorylation N T442 Q13618 8452 CUL3 KIAA0617 Kidney renal clear cell carcinoma Ubiquitination N K444 Q13618 8452 CUL3 KIAA0617 Pseudohypoaldosteronism Phosphorylation N S456 Q13618 8452 CUL3 KIAA0617 Lung adenocarcinoma Acetylation N K459 Q13618 8452 CUL3 KIAA0617 Pseudohypoaldosteronism Acetylation N K459 Q13618 8452 CUL3 KIAA0617 Lung adenocarcinoma Ubiquitination N K459 Q13618 8452 CUL3 KIAA0617 Pseudohypoaldosteronism Ubiquitination N K459 Q13618 8452 CUL3 KIAA0617 Skin cutaneous melanoma Ubiquitination N K469 Q13618 8452 CUL3 KIAA0617 Skin cutaneous melanoma Phosphorylation N S478 Q13618 8452 CUL3 KIAA0617 Uterine corpus endometrial carcinoma Phosphorylation N S478 Q13618 8452 CUL3 KIAA0617 Uterine corpus endometrial carcinoma Phosphorylation N T483 Q13618 8452 CUL3 KIAA0617 Colon adenocarcinoma Methylation N R536 Q13618 8452 CUL3 KIAA0617 Lung adenocarcinoma Methylation N R536 Q13618 8452 CUL3 KIAA0617 Thyroid carcinoma Methylation N R536 Q13618 8452 CUL3 KIAA0617 Uterine corpus endometrial carcinoma Phosphorylation N S585 Q13618 8452 CUL3 KIAA0617 Skin cutaneous melanoma Ubiquitination N K668 Q13618 8452 CUL3 KIAA0617 Colon adenocarcinoma Ubiquitination N K673 Q13618 8452 CUL3 KIAA0617 Skin cutaneous melanoma Ubiquitination N K673 Q13618 8452 CUL3 KIAA0617 Breast invasive carcinoma Ubiquitination N K680 Q13618 8452 CUL3 KIAA0617 Colon adenocarcinoma Ubiquitination N K680 Q13618 8452 CUL3 KIAA0617 Breast invasive carcinoma Phosphorylation N S684 Q13618 8452 CUL3 KIAA0617 Autosomal dominant pseudohypoaldosteronism Ubiquitination N K700 Q13618 8452 CUL3 KIAA0617 Head and neck squamous cell carcinoma Ubiquitination N K700 Q13618 8452 CUL3 KIAA0617 Hepatocellular carcinoma Ubiquitination N K700 Q13618 8452 CUL3 KIAA0617 Colon adenocarcinoma Phosphorylation N S737 Q13618 8452 CUL3 KIAA0617 Lung adenocarcinoma Phosphorylation N Y764